Fate Therapeutics, Inc. · NASDAQ:FATE
Fate Therapeutics, Inc. shareholders
As of Jun 30, 2026, 148 institutions reported holding Fate Therapeutics, Inc., 59.9% of its shares. Largest: Redmile Group, LLC, Vanguard and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Fate Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Redmile Group, LLC | 12.9M | 10.7% | no change | Aug 14, 2026 |
| Vanguard | 9.77M | 8.2% | +713K | Aug 13, 2026 |
| BlackRock | 7.3M | 6.1% | −2.77M | Aug 7, 2026 |
| Acadian Asset Management LLC | 4.35M | 3.6% | +231K | Aug 13, 2026 |
| AQR Capital Management LLC | 3.84M | 3.2% | +836K | Aug 14, 2026 |
| Two Sigma | 3.59M | 3.0% | +123K | Aug 14, 2026 |
| Johnson & Johnson | 3.38M | 2.8% | no change | Aug 6, 2026 |
| Renaissance Technologies | 2.98M | 2.5% | +8,585 | Aug 13, 2026 |
| Millennium | 2.43M | 2.0% | new | Aug 14, 2026 |
| Goldman Sachs | 2.05M | 1.7% | +721K | Aug 14, 2026 |